Kardiologiya

Papers
(The TQCC of Kardiologiya is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Chronic heart failure in the Russian Federation: what has changed over 20 years of follow-up? Results of the EPOCH-CHF study76
Proactive anti-inflammatory therapy with colchicine in the treatment of advanced stages of new coronavirus infection. The first results of the COLORIT study39
Steroid pulse -therapy in patients With coronAvirus Pneumonia (COVID-19), sYstemic inFlammation And Risk of vEnous thRombosis and thromboembolism (WAYFARER Study)32
Miocarditis in Patients with COVID-19 Confirmed by Immunohistochemical23
The Agreed Experts’ Position of the Eurasian Association of Therapists on Some new Mechanisms of COVID-19 Pathways: Focus on Hemostasis, Hemotransfusion Issues and Blood gas Exchange20
Subacute and chronic post-covid myoendocarditis: clinical presentation, role of coronavirus persistence and autoimmune mechanisms19
Clinical Characteristics and Factors Associated with Poor Outcomes in Hospitalized Patients with Novel Coronavirus Infection COVID-1918
Results of Open-Label non-Randomized Comparative Clinical Trial: “BromhexIne and Spironolactone for CoronаvirUs Infection requiring hospiTalization (BISCUIT)16
The risks of re-hospitalization of patients with heart failure with prolonged follow-up in a specialized center for the treatment of heart failure and in real clinical practice.14
How evaluate results of treatment in patients with COVID-19? Symptomatic Hospital and Outpatient Clinical Scale for COVID-19 (SHOCS-COVID)14
Proactive anti-inflammatory and anticoagulant therapy in the treatment of advanced stages of novel coronavirus infection (COVID-19). Case Series and Study Design: COLchicine versus ruxolitinib and sec14
Biomarkers in Heart Failure: Current and Future14
Analysis of influence of background therapy for comorbidities in the period before infection on the risk of the lethal COVID outcome. Data from the international ACTIV SARS-CoV-2 registry («Analysis o13
Analysis of mortality in patients with heart failure after de­compen­sation during long-term follow-up in specialized medical care and in real clinical practice13
The role of diastolic transthoracic stress echocardiography with incremental workload in the evaluation of heart failure with preserved ejection fraction: indications, methodology, interpretation. Exp12
Epidemiology of atrial fibrillation in a representative sample of the European part of the Russian Federation. Analysis of EPOCH-CHF study11
Comparison of clinical and echocardiographic parameters of patients with COVID-19 pneumonia three months and one year after discharge11
Comorbidity of arterial hyperten­sion and tension-type headache11
Use of Statins, Anticoagulants, Antiaggregants and Antiarrhythmic Drugs in Patients With COVID-19. The Agreed Experts’ Position of Russian Society of Cardiology, Eurasian Association of Therapists, Na10
Combination therapy at an early stage of the novel coronavirus infection (COVID-19). Case series and design of the clinical trial “BromhexIne and Spironolactone for CoronаvirUs Infection requiring hos10
Gut microbiota and systemic inflammation in patients with chronic heart failure10
Role of markers of inflammation and endothelial dysfunction in the prognosis of the development of cardiovascular complications in patients with coronary artery disease and metabolic syndrome after co9
Safety performance of rivaroxaban versus warfarin in patients with atrial fibrillation and advanced chro­nic kidney disease9
Refractory and Resistant Hypertension in Patients with Type 2 Diabetes Mellitus: Different Response to Renal Denervation9
Antihypertensive and Vasoprotective Effects of Combined Pharmacotherapy in Patients with Arterial Hypertension and Prediabetes9
Possibilities of modern biomarkers for assessing the risk of developing ventricular tachyarrhythmias and sudden cardiac death in patients with chronic heart failure9
Occupational Burnout, Psychological Status and Quality of Life in Primary Care Physicians Working in Outpatient Settings9
The use of diuretics in chronic heart failure. Position paper of the Russian Heart Failure Society8
Influence of Total Ischemic Time on Clinical Outcomes in Patients with ST-Segment Elevation Myocardial Infarction8
Erythrocyte membranes beta-adrenoreactivity changes after renal denervation in patients with resistant hypertension, relationship with antihypertensive and cardioprotective intervention efficacy8
Impact of microvascular injury various types on function of left ventricular in patients with primary myocardial infarction with ST segment elevation8
Right ventricular systolic dysfunction as a predictor of adverse outcome in patients with COVID-198
Registry of Acute Myocardial Infarction. REGION-MI – Russian Registry of Acute Myocardial Infarction8
Asymptomatic Hyperuricemia and Risk Of Cardiovascular and Renal Diseases8
Atrial Fibrillation and Mortality: Prognostic Factors and Direction of Prevention7
Myocardial injury in COVID-19 patients is associated with the thickness of epicardial adipose tissue7
Right Ventricular Longitudinal Strain in Acute Pulmonary Embolism and Right Ventricular Myocardial Infarction in Patients with McConnell’s Sign7
Prevalence of Advanced Chronic Kidney Disease in Patients with Nonvalvular Atrial Fibrillation Hospitalized in Cardiology Departments7
Soluble ST2 – as a biomarker, a tool for risk stratification and therapeutic target in patients with chronic heart failure7
Predictors of Left Atrial Severe Fibrosis in Patients with Nonvalvular Atrial Fibrillation6
Myocardial work in assessment of left ventricular systolic function6
The changes of left ventricular longitudinal systolic function depending on hypertension and its control: analysis in a population6
International register “Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients (ACTIV SARS-CoV-2)”6
Myocardial revascularization in Russian Federation for acute coronary syndrome in 2016-20206
Multifactor predictive model in patients with myocardial infarction based on modern biomarkers6
Factors of Progression and Occurrence of Atherosclerosis in Rheumatoid Arthritis6
Role of age, comorbidity and renin- angiotensin-aldosterone system in COVID-19. Effects of ACE inhibitors and angiotensin receptor blockers6
Atrial Fibrillation After Coronary Artery Bypass Surgery: Risk Factors, Prevention and Treatment6
Long-term Prognosis after Treatment of Total Occluded Coronary Artery is well Predicted by Neutrophil to High-Density Lipoprotein Ratio: a Comparison Study6
Treatment of patients with heart failure and preserved ejection fraction: reliance on clinical phenotypes6
Machine learning for the diagnosis of pulmonary hypertension6
Diastolic heart failure: 20 years later. Сurrent issues of pathoge­nesis, diagnosis and treatment of heart failure with preserved LVEF6
Left ventricular global function index as a predictor of adverse cardiovascular events in patients with acute coronary syndrome6
Factors Associated with the Increase in Spatial and Frontal QRS-T Angles in Patients with Inferior Myocardial Infarction5
ECG changes in COVID-195
Ways to solve the problem of heart failure statistics in clinical practice5
The profile of drug treatment in subjects aged over 50 years with hypertension in an urban russian population5
The association of growth differentiation factor 15 (GDF-15) level with extent of left atrial fibrosis in patients with nonvalvular atrial fibrillation5
Therapeutic approaches to the Rational Use of trip­le combination therapy with a fixed combination of amlodipine, indapamide and perindopril arginine (TRIPLE COMBINATION) in patients with hypertension5
Endothelial dysfunction and inflammation in patients with non-obstructive coronary arteries5
Cardiovascular Pathology in Patients With COVID-195
E-Selectin as a Marker of Endothelial Dysfunction in Patients with Coronary Artery Disease Including Those with Type 2 Diabetes Mellitus5
Clinical significance of different assesment methods of myocardial fibrosis in patients with hypertrophic cardiomyopathy.5
Early changes of energy metabolism, isoformic content and level of titin phosphorylation at diastolic dysfunction5
Physical training in patients with chronic heart failure: level of involvement, as well as psychosocial, anamnestic and iatrogenic factors that determine the motivation to practice5
Comprehensive geriatric assessment in elderly and senile patients with cardiovascular diseases. Expert opinion of the Russian Association of Gerontologists and Geriatricians5
123 I-MIBG scintigraphy in the assessment of heart failure prognosis and effectiveness of cardiac resynchronization therapy5
The relationship between uric acid to high-density lipoprotein cholesterol ratio and collateral index in patients with chronic total occlusion5
Efficacy and Safety of Combined Treament with Ivabradine and Metoprolol in Patients with Stable Angina Pectoris – a Systematic Review4
Comorbidity and Gender of Patients at Risk of Hospital Mortality After Emergency Percutaneous Coronary Intervention4
Influence of Omega-3 PUFA on Non-invasive factors determining the risk of arrhYthmias eXcess and sudden cardiac death in patients with HFpEF with ischemic etiology (ONYX)4
Prognostic value of epicardial fat thickness in coronary heart disease patients after myocardial revascularization4
Decompensated heart failure with reduced ejection fraction: overcoming barriers to improve prognosis in the “vulnerable” period after discharge4
Level of the growth differentiation factor-15 in patients with acute myocardial infarction4
Effectiveness of the Cox Maze-IV Procedure in Cardiac Surgery Patients With Atrial Fibrillation4
Expert consensus regarding treatment of iron deficiency in stable and decompensated patients with heart failure4
Hidden systolic dysfunction of the right ventricle in patients with increased pulmonary vascular resistance 3 months after COVID-19 pneumonia4
Guidelines for the Diagnosis and Management of Chronic Coronary Syndromes in Primary Health Care – the Issue of Acceptability for the Russian Federation4
Early cardiac electrical and structural changes in patients with non-obese non-alcoholic fatty liver disease4
Intra-aortic balloon pump in patients with myocardial infarction and cardiogenic shock of stages A and B4
Adherence to the treatment of pa­tients in the long-term supervision period after myocardial infarction (according to the REGATA register)4
Stroke Prevention in Patients with Atrial Fibrillation in Real Clinical Practice, Emphasis on Efficacy and Safety of Anticoagulant Therapy4
Comprehensive study of the composition of fish fat extracts and quantitative criteria for distinguishing standardized omega-3 polyunsaturated fatty acids extracts4
Clinical Predictors of Occurrence of Ventricular Tachyarrhythmias in Patients with Reduced Left Ventricle Ejection Fraction. Results of Single-Center Prospective Study4
The role of prognostic nutritional index in patients with non-ST segment elevation acute coronary syndrome4
Outpatient register of patients who have suffered a myocardial infarction (REGATA): prospective follow-up data and outcomes4
The Frequency of Type 2 Myocardial Infarction in the Structure of Hospital Mortality According to 7-Years Data of a State University Clinic4
Coenzyme Q-10 in the treatment of patients with chronic heart failure and reduced left ventricular ejection fraction: systematic review and meta-analysis4
Polymorphic locus rs1061624 of the ТNFR2 gene is associated with the development of arterial hypertension in males4
Infective Endocarditis with Unknown Etiology: Possibilities of Conquering and Role of Microbiologistics4
Drug Therapy and Adherence in Patients With Coronary Heart Disease: Results of the Russian Part of the EUROASPIRE V International Multicenter Study4
Machine Learning Methods for Prediction of Hospital Mortality in Patients with Coronary Heart Disease after Coronary Artery Bypass Grafting4
Dynamics of Regional Mortality Rates From Cardiac Causes in Russia 2019–20204
The ability of modern therapy to improve the prognosis of patients with HF: role of angiotensin neprilysin inhibitors and sodium-glucose cotransporter inhibitors4
Association of left bundle branch block definitions with response to cardiac resynchronisation therapy in patients with congestive heart failure4
Computed Tomography Coronary Angiography Possibilities in “High Risk” Plaque Identification in Patients with non-ST-Elevation Acute Coronary Syndrome: Comparison with Intravascular Ultrasound4
Lipid-Lowering Therapy for Primary Cardiovascular Prevention in Older Adults. Consensus Statement of the Russian Association of Gerontologists and Geriatricians, National Society on Atherosclerosis, R4
Рossibility of using European (HFA-PEFF) and American (H2FPEF) algorithms for diagnosing heart failure with preserved ejection fraction in Russian clinical practice4
The effectiveness of radiofrequency ablation and repeated cardioversion in combination with antiarrhythmic drug therapy in maintaining stable sinus rhythm in patients with atrial fibrillation and hear4
Overlapping Phenotype: Left Ventricular non-Compaction and Hypertrophic Cardiomyopathy4
New Possibilities to Reduce the Residual Risk in Patients with Ischemic Heart Disease4
Results of Minimally Invasive Valve-Sparing Aortic Root Valve Surgery: Propensity Score Matching Analysis4
Blood Adipokins in Young People with Early Ischemic Heart Disease on the Background of Abdominal Obesity4
The level of growth differentiation factor 15 as a predictor of left atrial thrombosis in patients with nonvalvular atrial fibrillation3
Atrial Fibrillation and Diabetes Mellitus: the Control of Thromboembolic Risk3
The Role of Neprilysin Inhibitors in the Treatment of Heart Failure with Preserved Ejection Fraction3
Assessment of the Dynamics of Oxidative Stress Indicators and Early Markers of Myocardial Damage and Dysfunction in Patients with Aggressive Lymphoproliferative Diseases During of Anticancer Therapy3
Expert Council Resolution. Practical Aspects of the Diagnosis and Correction of Potassium and Magnesium Deficiency States3
Iron deficiency in Russia heart failure patients. Observational cross-sectional multicenter study3
Sleep quality and ventilatory efficiency in elderly heart failure patients: a pilot study on the short-term effect of 4-week low-intensity aerobic exercise3
Hypertension in working age population: influence of gender and education3
Ischemic Mitral Regurgitation: Echocardiographic Algorithm, the Place of Three-Dimensional Transesophageal Echocardiography3
Role of Segmental and Global Left Ventricular Strain in Diagnosis of Acute Coronary Syndrome3
Clinical and laboratory associations of liver fibrosis indexes in patients with decompensated Chronic Heart Failure II-IV Functional Classes3
Red cell distribution width as a predictor of impaired exercise capacity in patients with heart failure3
Epicardial and subcutenious adipose tissue adiponectin gene expression in coronary artery disease patients3
Early Predictors of Heart Failure Progression in Patients After Myocardial Infarction3
Positive Effects of Perindopril on Microvascular Vessels in Patients With Chronic Heart Failure3
Heart failure with preserved left ventricular ejection fraction in patients with obstructive sleep apnea syndrome: prognostic value of biomarkers3
Focus ultrasound for cardiology practice. Russian consensus document3
Geriatric nutritional risk index is a predictor of recurrent percutaneous coronary intervention in patients with non-ST segment elevation myocardial infarction3
Experience of introducing a new form of organization of medical care for patients with heart failure in the Russian Federation3
Modification of the of the cardiometabolic profile using combined therapy of the angiotensin receptor-neprilysin inhibitor and empagliflozin in comorbid patients with Chronic Heart Failure and type 2 3
Extracellular matrix of the heart and its changes in myocardial fibrosis3
The value of indicators characterizing the state of the cardiovascular system in assessing the hospital prognosis of COVID-19 patients3
Features of anticoagulant therapy of atrial fibrillation in combination with impaired renal function3
Value of comparative studies of “real clinical practice” in modern cardiology. Position paper based on the expert council discussion dated 12/18/20203
Metabolomic profiling in patients with metabolic syndrome3
Atrial fibrillation in old age: risk management and features of the use of direct oral anticoagulants3
Cardiac Involvement in COVID-193
Prognostic Value of Residual Coronary Artery Lesions on the SYNTAX Scale in Patients with Acute Myocardial Infarction without SТ Segment Elevation in the Mid-Term Period3
Contrast Echocardiography with a Quantitative Assessment of Myocardial Perfusion in Patients with Previous Q-Wave Myocardial Infarction3
Efficacy and Safety of Anticoagulant Therapy in Patients With Various Forms of Atrial Fibrillation After Interventional Treatment. Results of a Three-Year Follow-up3
Speckle Tracking Stress Echocardiography on Treadmill in Assessment of the Functional Significance of the Degree of Coronary Artery Disease3
The value of the spatial QRS–T angle for assessing the severity of heart damage in patients with arterial hypertension3
Assessment of Awareness and Experience of Using off-label Drugs by Doctors of Clinical Specialties3
Circulating Neuregulin-1 and Chronic Heart Failure with Preserved Ejection3
The Incidence and Possible Predictors of Coronary Restenosis3
Management of radio-contrast allergy in radio-contrast allergic patients undergoing coronary angiography and intervention3
Ivabradine for Treatment of Heart Failure with Preserved Ejection Fraction3
The role of platelet glycoprotein IIb / IIIa inhibitors in current treatment of acute coronary syndrome3
The soluble guanylate cyclase stimulator riociguat is the first-line therapy for chronic thromboembolic pulmonary hypertension patients3
Idiopathic recurrent pericarditis – a new orphan autoinflammatory disease? A retrospective analysis of cases of idiopathic recurrent pericarditis and a design of а double-blind, randomized, placebo-co3
The use of systemic immune-inflammation index to predict new onset atrial fibrillation in the context of acute coronary syndrome3
Acute effects of energy drink consumption on left and right ventricular function – a 2-dimensional speckle tracking echocardiographic study2
The Effects of Preventive Counseling Followed by Remote Support Via Telephone on the Motivation to Change Lifestyle in Patients With High and Very High Cardiovascular Risk2
Chronic obstructive pulmonary disease in patients with coronary heart disease worsens long-term prognosis after percutaneous coronary interventions2
Mobile health technologies in cardiology2
Role of modified cardiovascular risk factors in development of oncologic diseases2
The importance of cardiorehabilitation in the era of modern treatment of cardio­vascular diseases2
Factors associated with atherosclerotic plaque echogenicity in patients aged 40-64 with carotid atherosclerosis2
The Study of Biochemical Factors of Calcification of Stable and Unstable Plaques in the Coronary Arteries of Man2
The effect of chemotherapy on endothelial function and microcirculation in patients with gastric cancer2
Safety and Effectiveness of Volumetric Computed Tomography of the Heart in Combination with a PharmacologicaTest with Adenosine Triphosphate in the Diagnosis of Coronary Heart Disease2
The Efficacy of Telemedicine Rehabilitation Programs In Regard Of Risk Factors Control In Patients With Paroxysmal Atrial Fibrillation Aftercatheter Ablation2
Hypoxia – as a Possible Regulator of the Activity of Epicardial Mesothelial Cells After Myocardial Infarction2
T-wave inversion in the precordial leads: сardiac and non-cardiac causes2
Anemia as a Risk Factor for Organ Dysfunctions in Patients Operated on Heart Valves2
Prediction-Determining Outcomes and Their Predictors in Atrial Fibrillation Patients Receiving Multicomponent Antithrombotic Therapy in Real Clinical Practice2
Prevention of Diastolic Dysfunction Caused by Doxorubicin by Mitochondrial Antioxidant Plastomitin2
Personalized medicine in non-communicable diseases: latest advances and future prospects2
Assessment of the structural and functional state of blood vessels in patients with hypertrophic cardiomyopathy2
Indicator Characterizing Carbonyl-Dependent Modification of Erythrocytic Superoxydismutase as a Biochemical Marker of Oxidative Stress in Coronary Heart Disease2
4D FLOW Magnetic Resonance Imaging in the Study of Blood Flow in Patients With Aortic Coarctation in the Long-Term After Surgery2
Recommendations of the Eurasian Arrhythmology Association (EURA) for the diagnosis and treatment of patients with arrhythmias and conduction disorders during the COVID-19 pandemic2
Pathophysiological basis and diagnosis of the cardiovascular system damage caused by coronavirus infection2
Possibilities of Magnetic Resonance Tomography in Diagnosis of Pulmonary Arterial Hypertension2
Anthra­cycline-Induced Cardiotoxicity: the Role of Genetic Predictors2
Epicardial fat Tissue Volumetry: Comparison of Semi-Automatic Measurement and the Machine Learning Algorithm2
Markers of endothelial dysfunction in patients with arterial hypertension exposed to occupational irradiation of  low intensity2
Predictors of tachycardia-induced cardiomyopathy in patients with first-time decompensation of chro­nic heart failure with reduced left ventricular ejection fraction of nonischemic etiology and persis2
Physicians’ adherence to the guidelines on the chronic heart failure diagnosis and treatment2
Efficiency of the Decision-Making Module in the Personalized Choice of an Anticoagulant2
Remote monitoring of patients with heart failure in real clinical practice2
The prevalence of hyperlipidemia and features of lipid-lowering therapy in patients with myocardial infarction according to the Russian register of acute myocardial infarction REGION-MI2
Experience with tafamidis in a patient with transthyretin amyloidosis2
Asymptomatic Hyperuricemia: Treatment Approaches According to the Risk of Cardiovascular and Renal Events2
The risk score for in-hospital mortality in patients with ST-segment elevation myocardial infarction2
Bone Remodeling Markers in Assessing of Sternal Reparative Regeneration in Patients With Carbohydrate Metabolism Disorders After Coronary Bypass Surgery2
The no-Reflow Phenomenon During Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction due to Massive Coronary Thrombosis. Pathogenesis and Predictors o2
Treatment and secondary prevention of venous thromboembolism in cancer patients2
Safety of low-dose prolonged infusion of tissue plasminogen activator therapy in patients with thromboembolic events in the intensive care unit2
Risk of Cardiovascular Complications in Patients with Persistent Atrial Fibrillation after Dissolution of a Thrombus in the Left Atrial Appendage2
Gender Differences in Vascular Stiffness Indicators and Daily Blood Pressure Profile in Patients with Arterial Hypertension and Depressive Disorders2
Computed Tomography Myocardial Perfusion Imaging With Transesophageal Atrial Pacing Stress Test in Patients With Borderline Stenoses in the Coronary Arteries: a Comparison With Fractional Flow Reserve2
Comparative analysis of tryptophan and downstream metabolites of the kynurenine and serotonin pathways in patients with arterial hypertension and coronary artery disease2
Evaluation of the relationship between anti-inflammatory cytokines and adverse cardiac remodeling after myocardial infarction2
C-reactive protein and its associations with сardiometabolic risk factors and echocardiographic indicators of heart failure: results of “Know your heart” study in Arkhangelsk2
Vulnerable atherosclerotic plaques of coronary arteries in patients with stable coronary artery disease: 12-months follow-up2
Is the Naples prognostic score useful for predicting heart failure mortality2
Blood urea nitrogen is associated with long-term all-cause mortality in stable angina pectoris patients: 8-year follow-up results2
The Prognostic Value of Neuregulin-1β in Heart Failure Patients With Preserved Ejection Fraction2
Mechanical Dyssynchrony for Prediction of the Cardiac Resynchronization Therapy Response in Patients with Dilated Cardiomyopathy2
Modern approaches to the organization of care for patients with heart failure2
Is Adiponectin Elevation Associated with Left Atrial Remodeling and Impaired Mechanical Functions? (a Speckle Tracking Study)2
Prevalence and characteristics of coronary artery fistula in adults: coronary angiographic analysis of 18,106 patients2
Efficacy and safety of new oral anticoagulants as part of triple antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome. Data from an observational study2
Heart reHeart remodeling in patients with severe systolic dysfunction due tocancer chemotherapymodeling in patients with severe systolic dysfunction due tocancer chemotherapy.2
Efficacy of secondary prevention and rehabilitation programs with distant support in patients with atrial fibrillation after intervention procedures: impact on psychological status2
Morphological and Molecular-Biological Changes in the Coronary Arteries after Stenting2
Clinical Manifestation of Stressful Cardiomyopathy (Takotsubo Syndrome) and the Problem of Differential Diagnosis with Acute Myocardial Infarction2
Significance of the echocardiographic evaluation of left atrial myocardial strain for early diagnosis of heart failure with preserved ejection fraction2
Analysis of healthcare for patients with cardiovascular diseases in Russian Federation in comparison with the practice of Europe and USA2
Diseases of the circulatory system in the Kyrgyz Republic in the period of 2002–20172
Combined Effect of Hypertension and Alcohol Consumption on the Risk of Death (27‑Year Cohort Prospective Study)2
Visual Scale as a Non-Invasive Method for Evaluation of Risk and Severity of Coronary Atherosclerosis2
The Effect of Bromocriptine on Clinical and Laboratory Parameters in Patients With Peripartum Cardiomyopathy2
The frequency and profile of drug treatment in subjects with dyslipidemias and cardimetabolic diseases in an urban russian population older then 55 years2
Comparison of Different Intensity Modes of Neuromuscular Electrical Stimulation in the Rehabilitation of Elderly Patients with Decompensated Chronic Heart Failure2
Myocardial infarction with nonobstructive coronary arteries2
0.048691987991333